Melanoma Focus Virtual Regional Meeting
Friday 12th May 2023
Organised by: Professor Marianne Nicolson, Consultant Medical Oncologist, Raigmore Hospital, Inverness
Location: Virtual
Friday, 12th May 2023 | 9:00 am – 5:30 pm |
The Royal Colleges of Physicians of the United Kingdom have awarded up to 6 CPD credits. The Royal College of Surgeons of England has awarded up to 5.5 CPD points and the British Association of Plastic, Reconstructive and Aesthetic Surgeons have awarded up to 7 CME points.
If you are unsure about your membership, please email memberships@melanomafocus.org
PROGRAMME
09:00-09:15 | Welcome/Introductions (Dr Mark Harries / Susanna Daniels/Professor Marianne Nicolson) |
09:15-10:00 | Neoadjuvant treatment of melanoma Professor Paolo Ascierto, Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute Fondazione G. Pascale, Naples |
10:10-11:25 | Session 1: Progress in stage 2/3 melanoma Chair: Professor Marianne Nicolson, Consultant Medical Oncologist, Raigmore Hospital, Inverness |
10:10 – 10:40 | Adjuvant therapy for resected melanoma – where are we now? Dr Pippa Corrie, Consultant Medical Oncologist, Cambridge University Hospitals NHS Foundation Trust |
10:40 – 11:10 | SLNB: An update on accuracy and eligibility Mr Neil Cahoon, Consultant Plastic Surgeon, Edinburgh |
11:10 – 11:25 | Q&A |
11:25 – 13:30 | Pharma Exhibition Area / Posters |
11:30– 12:30 | Pharma Sponsored Symposium: IMMUNOCORE
KIMMTRAK (Tebentafusp) – A New Treatment Option for patients with HLA-A*02:01 positive metastatic Uveal Melanoma
NHS Real World Experience and Future Service Considerations |
13:30 – 14:45 | Session 2: Optimising diagnosis today and new horizons for tomorrow Chair: Dr Ewan Brown, Consultant Medical Oncologist, Western General Hospital, Edinburgh |
13:30 – 14:00 | Diagnostic dilemmas in melanocytic pathology Dr Asok Biswas, Consultant Dermatopathologist and Honorary Senior Lecturer, Weston General Hospital and The University of Edinburgh |
14:00 – 14:30 | Transcriptional heterogeneity in melanoma and residual disease Dr Jana Travnickova, Research Fellow, MRC Human Genetics Unit and Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Edinburgh |
14:30 – 14:45 | Q&A |
14:45 – 14:55 | Comfort Break |
14:55 – 16:10 | Session 3: Teledermatology practice changes Chair: Mr Kaz Rahman, Consultant Plastic Surgeon, NHS Grampian & Clinical Director for Skin Cancer, North Cancer Alliance |
14:55 – 15:25 | Enhancement of clinical practice through teledermatology Dr Alyson Bryden, Consultant Dermatologist, Ninewells Hospital, Dundee |
15:25 – 15:55 | Digital healthcare intervention for melanoma survivors: the next steps? Professor Peter Murchie, Professor of General Practice, University of Aberdeen |
15:55 – 16:10 | Q&A |
16:15 – 17:25 | Session 4: MDT – Management of metastatic uveal melanoma (case-based discussions) Chair: Dr Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre Panel: |
17:25 – 17:30 | Concluding Remarks and Close Dr Mark Harries, Chairman Melanoma Focus, Professor Marianne Nicolson, Organiser |